ALZN – alzamend neuro, inc. (US:NASDAQ)
Stock Stats
News
Alzamend Neuro (NASDAQ:ALZN) had its price target lowered by analysts at Ascendiant Capital Markets from $42.00 to $28.00. They now have a "buy" rating on the stock.
Form DEFA14A Alzamend Neuro, Inc.
Form DEF 14A Alzamend Neuro, Inc. For: Apr 17
Form PRE 14A Alzamend Neuro, Inc. For: Apr 17
Form 4 Alzamend Neuro, Inc. For: Dec 23 Filed by: AULT MILTON C III
Form 4 Alzamend Neuro, Inc. For: Dec 19 Filed by: Horne William B.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.